Page 57 - Mesenchymal Stem Cell-Derived Exosomes as an Emerging Paradigm for Regenerative Therapy and Nano-Medicine
P. 57

Yin et al. Biomarker Research             (2019) 7:8                                     Page 4 of 8





            ischaemia reperfusion injury model, injection of bone  large amounts of neprilysin, the most prominent en-
            marrow-derived  MSCs-derived  exosomes  reduced   zyme that degrades β-amyloid peptide in the brain.
            apoptosis and myocardial infarct size and subse-  Transfer of exosomes into neuroblastoma N2a cells
            quently improved heart functions by inducing cardio-  led to reductions in both secreted and intracellular
            myocyte autophagy via AMPK/mTOR and Akt/mTOR      β-amyloid peptidelevels, whichmight beathera-
            pathways [47].                                    peutic approach to Alzheimer’s disease [51]. The re-
                                                              sults  of  migration  assay  and  capillary  network
            Neurological disease                              formation assay showed that exosomes secreted by
            MSC-Exosomes have shown potential therapeutic     adipose-derived stem cells (ADSCs-Exos) promoted
            benefit in the treatment of neurological and neurode-  the mobility and angiogenesis of brain microvascular
            generative diseases. One of the most outstanding re-  endothelial  cells  (BMECs)  after  oxygen-glucose
            sults in the field is the fact that systemically injected  deprivation (OGD) via miR-181b-5p/TRPM7 axis [52].
            exosomes are able to cross the blood-brain barrier  Injection of exosomes from mouse bone marrow
            (BBB) and achieve the brain parenchyma. Systemic  MSCs could rescue cognition and memory impair-
            delivery of targeted exosomes containing a siRNA  ment according to results of the Morris water maze
            against α-synuclein reduced the mRNA and protein  test, reduced plaque deposition, and Aβ levels in the
            levels of α-synuclein in the brain [48, 49]. Xin et al.  brain; could decrease the activation of astrocytes and
            also reported that rat bone marrow derived MSCs de-  microglia; could down-regulate proinflammatory cyto-
            rived EVs enriched with the miR-17-92 cluster en-  kines (TNF-α and IL-1β); and could up-regulate
            hanced   oligodendrogenesis  neurogenesis  neural  anti-inflammatory cytokines (IL-4 and -10) in AD
            plasticity and functional recovery after stroke possibly  mice, as well as reduce the activation of signal trans-
            by suppressing PTEN and subsequently by increasing  ducer and activator of transcription 3 (STAT3) and
            the phosphorylation of proteins downstream of PTEN  NF-κBinAPP/PS1doubletransgenicmice[53].
            including of the protein kinase B/mechanistic target
            of rapamycin/glycogen synthase kinase 3β signaling  Immune disease Potent immunomodulatory properties
            pathway [50]. Katsuda et al. used exosomes secreted  of MSCs-exo has been evaluated. Exosomes have been
            from human adipose tissue-derived MSCs that contain  observed to play crucial roles in carrying and presenting





































              Fig. 1 Therapeutic effects of MSC-derived exosomes. Exosomes from MSCs contain multiple proteins, lipids, RNAs (mRNA, miRNA, ncRNA).
              Therapeutic effects of MSC-derived exosomes in liver, kidney, cardiovascular, and neurological diseases
   52   53   54   55   56   57   58   59   60   61   62